Fortis Group Advisors’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $12.8K | Buy |
69
+36
| +109% | +$6.68K | ﹤0.01% | 321 |
|
|
2025
Q1 | $6.91K | Hold |
33
| – | – | ﹤0.01% | 326 |
|
|
2024
Q4 | $5.86K | Hold |
33
| – | – | ﹤0.01% | 350 |
|
|
2024
Q3 | $6.52K | Hold |
33
| – | – | ﹤0.01% | 336 |
|
|
2024
Q2 | $5.66K | Sell |
33
-1,766
| -98% | -$303K | ﹤0.01% | 341 |
|
|
2024
Q1 | $328K | Sell |
1,799
-128
| -7% | -$23.3K | 0.06% | 158 |
|
|
2023
Q4 | $307K | Buy |
1,927
+33
| +2% | +$5.25K | 0.08% | 98 |
|
|
2023
Q3 | $301K | Buy |
1,894
+33
| +2% | +$5.25K | 0.09% | 96 |
|
|
2023
Q2 | $251K | Hold |
1,861
| – | – | 0.07% | 116 |
|
|
2023
Q1 | $281K | Buy |
+1,861
| New | +$281K | 0.08% | 97 |
|
|
2020
Q3 | $267K | Buy |
+3,065
| New | +$267K | 0.05% | 159 |
|